Prenetics Global Limited (NASDAQ:PRENW) Short Interest Down 96.5% in July

Prenetics Global Limited (NASDAQ:PRENW) was the target of a large decrease in short interest in the month of July. As of July 31st, there was short interest totaling 27,675 shares, a decrease of 96.5% from the July 15th total of 787,526 shares. Based on an average daily volume of 29,679 shares, the days-to-cover ratio is presently 0.9 days.

Prenetics Global Trading Down 15.4%

Shares of Prenetics Global stock traded down $0.00 on Thursday, hitting $0.01. 2,877 shares of the company traded hands, compared to its average volume of 38,427. Prenetics Global has a 52 week low of $0.01 and a 52 week high of $0.04. The business has a 50-day simple moving average of $0.01 and a 200 day simple moving average of $0.02.

About Prenetics Global

Prenetics Global (NASDAQ: PRENW) is a molecular diagnostics and preventive genomics company that develops and delivers DNA-based tests and diagnostic solutions. The company’s offerings include direct-to-consumer health profiling services, clinical genetic tests, and pathogen screening assays. By combining advanced laboratory processes with digital tools, Prenetics aims to provide insights into genetic risk factors, nutrition and fitness optimization, and early disease detection.

Prenetics operates a portfolio of consumer genomics brands, including DNAFit and CircleDNA, which offer personalized reports on wellness, exercise, nutrition, and inherited health traits.